5269532026-01-012026-03-315269532026-03-315269532025-03-315269532025-04-012026-03-315269532026-01-012026-03-31in-capmkt:OtherExpenses1Member5269532026-01-012026-03-31in-capmkt:OtherExpenses2Member5269532025-04-012026-03-31in-capmkt:OtherExpenses1Member5269532025-04-012026-03-31in-capmkt:OtherExpenses2Member5269532026-03-31OtherNoncurrentFinancialAssetsDomain15269532026-03-31OtherNoncurrentAssetsDomain15269532026-03-31OtherNoncurrentAssetsDomain25269532026-03-31OtherCurrentFinancialAssetsDomain15269532026-03-31OtherCurrentAssetsDomain15269532026-03-31OtherNoncurrentLiabilitiesDomain15269532026-03-31OtherCurrentFinancialLiabilitiesDomain15269532026-03-31OtherCurrentFinancialLiabilitiesDomain25269532026-03-31OtherCurrentLiabilitiesDomain15269532026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15269532025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15269532026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15269532025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15269532026-01-012026-03-31RelatedPartyTransactionDomain15269532025-12-31RelatedPartyTransactionDomain15269532026-03-31RelatedPartyTransactionDomain15269532026-01-012026-03-31RelatedPartyTransactionDomain25269532025-12-31RelatedPartyTransactionDomain25269532026-03-31RelatedPartyTransactionDomain25269532026-01-012026-03-31RelatedPartyTransactionDomain35269532025-12-31RelatedPartyTransactionDomain35269532026-03-31RelatedPartyTransactionDomain35269532026-01-012026-03-31RelatedPartyTransactionDomain45269532025-12-31RelatedPartyTransactionDomain45269532026-03-31RelatedPartyTransactionDomain45269532026-01-012026-03-31RelatedPartyTransactionDomain55269532025-12-31RelatedPartyTransactionDomain55269532026-03-31RelatedPartyTransactionDomain55269532026-01-012026-03-31RelatedPartyTransactionDomain65269532025-12-31RelatedPartyTransactionDomain65269532026-03-31RelatedPartyTransactionDomain65269532026-01-012026-03-31RelatedPartyTransactionDomain75269532025-12-31RelatedPartyTransactionDomain75269532026-03-31RelatedPartyTransactionDomain75269532026-01-012026-03-31RelatedPartyTransactionDomain85269532025-12-31RelatedPartyTransactionDomain85269532026-03-31RelatedPartyTransactionDomain85269532026-01-012026-03-31RelatedPartyTransactionDomain95269532025-12-31RelatedPartyTransactionDomain95269532026-03-31RelatedPartyTransactionDomain95269532026-01-012026-03-31RelatedPartyTransactionDomain105269532025-12-31RelatedPartyTransactionDomain105269532026-03-31RelatedPartyTransactionDomain105269532026-01-012026-03-31RelatedPartyTransactionDomain115269532025-12-31RelatedPartyTransactionDomain115269532026-03-31RelatedPartyTransactionDomain115269532026-01-012026-03-31RelatedPartyTransactionDomain125269532025-12-31RelatedPartyTransactionDomain125269532026-03-31RelatedPartyTransactionDomain125269532026-01-012026-03-31RelatedPartyTransactionDomain135269532025-12-31RelatedPartyTransactionDomain135269532026-03-31RelatedPartyTransactionDomain135269532026-01-012026-03-31RelatedPartyTransactionDomain145269532025-12-31RelatedPartyTransactionDomain145269532026-03-31RelatedPartyTransactionDomain145269532026-01-012026-03-31RelatedPartyTransactionDomain155269532025-12-31RelatedPartyTransactionDomain155269532026-03-31RelatedPartyTransactionDomain155269532026-01-012026-03-31RelatedPartyTransactionDomain165269532025-12-31RelatedPartyTransactionDomain165269532026-03-31RelatedPartyTransactionDomain165269532026-01-012026-03-31RelatedPartyTransactionDomain175269532025-12-31RelatedPartyTransactionDomain175269532026-03-31RelatedPartyTransactionDomain175269532026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares526953VENUSREMNOTLISTEDINE411B01019VENUS REMEDIES LIMITEDMain BoardEquity2025-04-012026-03-312026-05-262026-05-15INRCroresQuarterlyFourth quarterSingle segmentPHARMACEUTICALS2026-05-2615:15:002026-05-2621:35:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2026-05-26https://venusremedies.com/investorinformationfalsefalseNO SUCH TRANSACTION2026-01-012026-03-31AuditedStandalone2590100000464000002636500000116250000047300000-1450000023620000006500000056420000020607000005758000000575800000144800000-370000014110000004347000000000434700000-548000003799000001337000001032.5132.510032.5132.512025-04-012026-03-31AuditedStandalone768730000011450000078018000003879500000107600000-114700000848500000024690000015272000006495000000130680000001306800000328900000-15200000313700000099310000000009931000008300000100140000013370000010689630000074.2974.290074.2974.29Selling, Manufacturing and administrative expoenses506200000Research and Development58000000Selling, Manufacturing and administrative expoenses1342800000Research and Development18440000011023000005136000000092200000000016395000000363400000200290000016170000047025000001293700000738000000116390000023540000044900000036000002185800000818000004968000004058100000008760600000133700000676260000068963000006896300000002810000014340000001105000002820000000124100000983600000110770000041180000015195000001960000043200000158230000018643000008760600000Other Financial Assets363400000Other Non current assets39800000Right of use assets121900000Other Financial Assets3600000Other current assets496800000Lease Liability110500000Lease Liability13600000Other Financial liability398200000Other current liabilities1960000055000000-12200000000-35500000000534000000000246900000032000000000021400000-594000000000005513000001858100000000342700000-4500000151090000000000000190000037660000001525600000000000000000000021400000063200000-1815700000000000000084000000550000000-13900000-3187000000-318700000554100000235400000Items that will not be reclassified to profit & loss38000003800000Items that will not be reclassified to profit & loss1200000120000000Items that may be reclassified to Profit & Loss-58600000-58600000Items that may be reclassified to Profit & Loss7100000710000000-548000008300000VENUS REMEDIES LIMITED******Sunev Pharma Solutions Private Limited******Entity in which directors are interestedAny other transactionRent0Approved000VENUS REMEDIES LIMITED******Spine Software Sysytems Pvt Ltd******Entity in which directors are interestedAny other transactionRent2100000Approved2100000400000-400000VENUS REMEDIES LIMITED******Spine Software Sysytems Pvt Ltd******Entity in which directors are interestedPurchase of goods or services24000000Approved2240000015000004600000VENUS REMEDIES LIMITED******Spine Software Sysytems Pvt Ltd******Entity in which directors are interestedAny other transactionCanteen charges200000Approved20000000VENUS REMEDIES LIMITED******Tark AI Private Limited******Entity in which directors are interestedAny other transactionRent received0Approved000VENUS REMEDIES LIMITED******Tark AI Private Limited******Entity in which directors are interestedAny other transactionCanteen charges0Approved000VENUS REMEDIES LIMITED******Tark AI Private Limited******Entity in which directors are interestedPurchase of goods or services6400000Approved630000012000001200000VENUS REMEDIES LIMITED******Pawan Chaudahry******KMPRemuneration8100000Approved7200000700000800000VENUS REMEDIES LIMITED******Manu Chaudhary******KMPRemuneration8100000Approved7100000700000800000VENUS REMEDIES LIMITED******Peeyush Jain******KMPRemuneration5000000Approved4300000500000500000VENUS REMEDIES LIMITED******Ashutosh Jain******KMPRemuneration4700000Approved4300000500000500000VENUS REMEDIES LIMITED******Akshansh Chaudhary******KMPRemuneration3500000Approved3100000300000400000VENUS REMEDIES LIMITED******Saransh Chaudhary******PROMOTER'S RELATIVERemuneration5000000Approved4400000400000400000VENUS REMEDIES LIMITED******Aditi K Chaudhary******PROMOTER'S RELATIVERemuneration1900000Approved2100000200000300000VENUS REMEDIES LIMITED******Venus Pharma GmbH******Entity in which directors are interestedPurchase of goods or services151000000Approved151000000122000000137400000VENUS REMEDIES LIMITED******Venus Foundation Trust******CSR TRUSTAny other transactionCSR Implementing agency10000000Approved1000000000VENUS REMEDIES LIMITED******Venus remedies Limited Gratuity Trust******Gratuity TrustAny other transactionTransfer of Gratuity38900000Approved3890000000263400000AuditedtrueJ K Jain & Associatestrue2027-04-30